23andMe Holding Co. (ME)
NASDAQ: ME
· Real-Time Price · USD
0.61
0.00 (0.61%)
At close: Mar 28, 2025, 3:59 PM
23andMe Revenue Breakdown
| Period Ending | Mar 31, 2025 | Mar 31, 2024 | Mar 31, 2023 | Mar 31, 2022 |
|---|---|---|---|---|
| Research Services Revenue | 23.39M | 27.5M | 52.35M | 221.89M |
| Research Services Revenue Growth | -14.95% | -47.47% | -76.41% | n/a |
| Consumer Services Revenue | 166.51M | 202.31M | 247.14M | 50.01M |
| Consumer Services Revenue Growth | -17.70% | -18.14% | +394.22% | n/a |
Revenue by Geography
| Period Ending | Mar 31, 2025 | Mar 31, 2024 | Mar 31, 2023 | Mar 31, 2022 |
|---|---|---|---|---|
| Canada Revenue | 8.64M | 10.56M | 13.58M | 14.29M |
| Canada Revenue Growth | -18.18% | -22.21% | -4.98% | n/a |
| Other Regions Revenue | 3.95M | 4.64M | 5.64M | 6.68M |
| Other Regions Revenue Growth | -14.78% | -17.77% | -15.59% | n/a |
| United Kingdom Revenue | 28.14M | 24.28M | 63.02M | 58.48M |
| United Kingdom Revenue Growth | +15.89% | -61.47% | +7.77% | n/a |
| United States Revenue | 149.16M | 180.15M | 217.24M | 192.44M |
| United States Revenue Growth | -17.20% | -17.07% | +12.89% | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 29.79M | 42.73M | 43.35M | 40.29M | 47.83M | 39.23M | 57.18M | 40.98M | 70.76M | 48.54M | 70.58M | 50.45M | 63.08M | 66.19M | 71.43M | 29.85M | 28.02M | 66.01M | 28.85M | 22.64M | 24.85M |
| Selling, General, and Administrative Revenue Growth | -30.29% | -1.44% | +7.59% | -15.76% | +21.94% | -31.40% | +39.54% | -42.09% | +45.79% | -31.23% | +39.90% | -20.02% | -4.70% | -7.35% | +139.29% | +6.56% | -57.56% | +128.83% | +27.39% | -8.86% | n/a |
| Research and Development Revenue | 14.45M | 21.54M | 20.22M | 41.04M | 42.76M | 46.72M | 41.72M | 54.59M | 62.33M | 60.72M | 57.27M | 52.6M | 52.01M | 50.32M | 50.3M | 44.52M | 44.23M | 45.6M | 41.68M | 38.2M | 34.37M |
| Research and Development Revenue Growth | -32.91% | +6.55% | -50.74% | -4.01% | -8.49% | +11.99% | -23.57% | -12.42% | +2.65% | +6.02% | +8.88% | +1.13% | +3.35% | +0.05% | +12.97% | +0.66% | -2.99% | +9.38% | +9.11% | +11.16% | n/a |
| Sales and Marketing Revenue | 6.47M | 8.28M | 12.67M | 16.87M | 8.61M | 10.5M | 21.61M | 11.03M | 15.32M | 21.78M | 39.88M | 16.27M | 33.43M | 29.35M | 35.77M | 13.59M | 15.42M | 22.58M | 8.76M | 8.33M | 10.65M |
| Sales and Marketing Revenue Growth | -21.88% | -34.68% | -24.90% | +95.98% | -17.98% | -51.43% | +95.89% | -27.97% | -29.66% | -45.39% | +145.08% | -51.33% | +13.91% | -17.93% | +163.21% | -11.87% | -31.72% | +157.77% | +5.19% | -21.83% | n/a |